Search by Tag: biopharmaceutical


108 total news stories found.


Pharmaceutical Intellectual Property, IP Intensive Industries, Better at Creating Jobs, Sustaining Economic Growth According to New U.S. Chamber Study

2010-05-26 | Study emphasizes importance of "IP Intensive" industries for American productivity, global competitiveness.


Crossbeta Biosciences Completes Financing Round and Appoints Guus Scheefhals as CEO

2010-04-14 | Today, Crossbeta Biosciences announced that it has successfully completed a financing round of up to EUR2 million and appointed Guus Scheefhals as Chief Executive Officer.


Donors Welcome the Advance Market Commitment's First Long-Term Supply Commitments From Leading Pharmaceutical Companies Providing Access to Medicine for Millions

2010-04-10 | Global Health Progress applauds world's poorest countries' ability to access pneumococcal disease vaccines


Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome

2009-07-20 | Heptax, the Company's lead compound, reduces cholesterol, triglycerides, blood pressure, liver enzymes, and fasting blood glucose levels in animal models of metabolic syndrome and liver disease. It also raised levels of HDL, the "good cholesterol."


Norwich Pharmaceuticals Announces Alliance with Emerson Resources

2009-07-14 | Norwich Pharmaceuticals, Inc., a perennial industry leader in contract manufacturing and packaging, has announced the formation of a strategic alliance with Emerson Resources, Inc.


Norwich Announces Potent Compound Development Capability

2009-06-11 | Norwich Pharmaceuticals, Inc., an industry leader in contract manufacturing and packaging, is now offering comprehensive services toward the development of high-potency compounds in solid, semi-solid, and liquid dosage forms.


Biotechnology Investor Research Available; Updated Directory of Biotech Stocks for 2009

2009-01-25 | BiotechIndustryStocks.com, a global investor website for the biotechnology sector within Investorideas.com, updates its current content with an expanded stock directory for the sector.



Send your news using our proprietary press release distribution software platform. A leading press release service provider since 2004.

Contact Info

  • Email Us Online
  • +1 888-880-9539
  • Our Telephone Hours:
    8:30am to 5:00pm PST (Mon - Fri)
  • US Address:
    Smith Tower, Suite 1400 - 506 Second Avenue
    Seattle, WA 98104

© 2004-2024 24-7 Press Release Newswire. All Rights Reserved.